Albemarle Corporation (ALB) | The Buildout — AI Infrastructure
The Verdict
Albemarle produces lithium compounds, bromine, and specialty chemicals. Its business matters to the AI buildout mainly through lithium used in stationary storage batteries, which management describes as the fastest and most cost-effective way to support grid reliability as data-center electricity demand grows. A smaller, unquantified link runs through specialty chemicals sold into electronics and semiconductor applications.
| Market Cap | — |
| Revenue (TTM) | $5.5B |
| Revenue Growth | +7.9% |
| EBITDA Margin (TTM) | 17.5% |
| Net Debt | $792M |
| Earnings Beats | 4 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- Q2 adjusted EBITDA rose 155% YoY to $858M, and enterprise EBITDA margin reached 49%.
- Q2 operating cash conversion was more than 80%, with $710M operating cash flow and $638M free cash flow.
- Lithium demand is tracking above management's forecast: global lithium consumption through May was up 45% YoY.
- Stationary storage forecasts were raised to 900–1,100 GWh for 2026, and the 2030 low end was raised to 1,500 GWh.
- Balance sheet de-risked: $1.3B debt repaid in Q1, net debt-to-EBITDA leverage 1.0x.
What We’re Watching
- Q3 2026 net sales and adjusted EBITDA are guided lower sequentially, with Energy Storage margins down on spodumene cost lag.
- CGP3 full run rate is delayed to Q1 2027; 2026 Energy Storage volumes were cut to 225,000–235,000 tons LCE.
- Two major long-term contracts roll off at year-end 2026 with no renewal outcome disclosed.
- Middle East supply-chain disruption carries an unmitigated full-year cost of $70–90 million.
The near-term thesis is strengthening on lithium demand and cash generation, but management itself has pulled forward a guided Q3 reset. The core bullish evidence — tight inventories, storage demand above forecast, and strong Q2 cash conversion — is intact. The open question is whether the Q3 decline is contained or larger than the disclosed spodumene and bromine effects.
Earnings Beat
Q2 2026 net sales were $1.7 billion, up 31% year over year. Adjusted EBITDA was $858 million, more than doubled year over year, and enterprise EBITDA margin reached 49%. Operating cash conversion was more than 80% in the quarter.
| Metric | Q1 FY2026 | Q4 FY2025 | Q1 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $1.4B | $1.4B | $1.1B | +32.7% |
| Gross margin | 35.1% | 14.2% | 14.3% | +2080bps |
| EBITDA | $391M | $212M | $181M | +115.9% |
| EPS | $2.69 | $-3.52 | $0.35 | +666.1% |
| Energy Storage volumes | 65,000 tons LCE | 53,000 tons LCE | n/a | — |
EVs were weak in the first quarter, but they kind of trended back in the second quarter and then energy storage demand is kind of off the charts.— Kent Masters, CEO, August 5/6, 2026
Management tone: Management was confident but measured: it described demand as strong while volunteering the CGP3 fire, Q3 sequential decline, spodumene cost lag, bromine normalization, Middle East uncertainty, and low inventory levels. The team was direct on operational and market questions and reframed or deflected on relationship and policy questions.
Management Guidance
Management maintained the total-company outlook and expects results at the high end of the $20/kg LCE scenario ranges. It raised Specialties guidance to net sales of $1.4–$1.6 billion and adjusted EBITDA of $275–$325 million. Energy Storage 2026 volumes were cut to 225,000–235,000 tons LCE, flat to down 4%. For Q3 2026, net sales and adjusted EBITDA are expected lower sequentially, with Energy Storage margins down on the spodumene cost lag. Cost and productivity savings are on track to the high end of $100–$150 million.
Trajectory
Revenue is accelerating: Q1 FY2026 revenue was $1,428.7M, essentially flat versus Q4 FY2025, before Q2 2026 net sales of $1.7B, up 31% year over year. Q1 FY2026 gross margin was 35.1%, and Q2 enterprise EBITDA margin reached 49%. The driver is pricing — Energy Storage pricing was up 73% in Q2 — while volume is constrained by the CGP3 fire and Wodgina is offsetting.
The Model
The model's locked projections show FY+1 revenue of $6,400M and EBITDA of $2,944M, a 46.0% margin, then FY+2 revenue of $7,150M and EBITDA of $3,396M, a 47.5% margin. Near-term is anchored by lithium tightness and the CGP3 ramp; FY+2 builds on stationary storage demand and the 2027 volume framework.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $5.1B | $6.4B | $7.2B |
| YoY Growth | — | +24.4% | +11.7% |
| EBITDA | $750M | $2.9B | $3.4B |
| EBITDA Margin | 14.6% | 46.0% | 47.5% |
Projections are the median of 5 independent model runs. The model’s revenue sits 8.3% above analyst consensus.
Management maintained the total-company outlook and expects results at the high end of the $20/kg LCE scenario ranges. It raised Specialties guidance to net sales of $1.4–$1.6 billion and adjusted EBITDA of $275–$325 million. Energy Storage 2026 volumes were cut to 225,000–235,000 tons LCE, flat to down 4%. For Q3 2026, net sales and adjusted EBITDA are expected lower sequentially, with Energy Storage margins down on the spodumene cost lag. Cost and productivity savings are on track to the high end of $100–$150 million.
What Could Go Right — and Wrong
- DLE reaches FID and permits are approved, converting a pilot with over 90% lithium recovery into commercial resource access at Salar de Atacama.
- The two expiring year-end 2026 contracts renew or are replaced at similar or higher volumes, reducing spot exposure.
- Stationary storage production again comes in above the raised 900–1,100 GWh 2026 forecast, extending lithium tightness.
- A structural Western lithium premium emerges, improving economics for Kemerton and Kings Mountain.
- Wodgina's ore availability and recovery outperformance proves structural, adding low-cost volume.
- CGP3 has another setback, delaying full run rate beyond Q1 2027 and removing expected high-single-digit 2027 volume growth.
- Lithium supply returns faster than expected from African supply or Chinese lepidolite restarts, breaking physical tightness.
- Lithium prices fall and stay down while more volume shifts to spot and short-duration contracts, reducing earnings protection.
- The two major contracts roll off without replacement, forcing volume into spot markets.
- Bromine normalizes harder than expected after peaking in April, giving back Specialties margin expansion.
Looking Ahead
The next 12 months hinge on the CGP3 ramp, spodumene cost timing, and the two year-end contract roll-offs. Management has guided Q3 2026 lower sequentially, expects CGP3 full run rate in Q1 2027, and reaffirmed a 2027 Energy Storage volume framework of 240,000–260,000 tons LCE. Longer term, DLE permitting and Australian brownfield FIDs remain pre-commitment.
- Q3 2026Q3 results — Tests whether the guided sequential decline is contained.
- Late 2026CGP3 ramp — Sustained restart operation without further setbacks.
- Year-end 2026Two major contracts roll off — Renewal or replacement terms set 2027 volume mix.
- Q1 2027CGP3 full run rate — Expected high-single-digit 2027 volume growth depends on it.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $5.4B | $5.1B | $5.5B | -4.4% |
| Gross Margin | 1.3% | 13.1% | 18.5% | +1,172bps |
| EBITDA | −$39M | $750M | $9.6B | +2017.4% |
| EBITDA Margin | -0.7% | 14.6% | 17.5% | +1,531bps |
| Net Income | −$1.2B | −$511M | −$233M | +56.7% |
| Free Cash Flow | −$1.0B | $692M | −$777M | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)18.5%
- EBITDA Margin (TTM)17.5%
- Net Margin (TTM)-4.2%
- ROIC2.3%
- FCF Conversion60.1%
- SBC / Revenue0.7%
The Company
Albemarle produces lithium, bromine, and specialty chemicals, organized into Energy Storage and Specialties after the Q1 2026 sale of the controlling stake in Ketjen. Energy Storage develops and manufactures lithium carbonate, lithium hydroxide, and lithium chloride for battery and cathode customers, primarily EVs and stationary energy storage. Specialties includes bromine and bromine derivatives, butyllithium, lithium aluminum hydride, cesium products, and zirconium/barium/titanium products. More than half of net sales are in new-energy end markets.
Albemarle operates an integrated footprint across Chile, Australia, China, the U.S., Jordan, Germany, Taiwan, Brazil, the Netherlands, and Japan. Its footprint includes the Salar de Atacama, Greenbushes, Wodgina, Silver Peak, and Kings Mountain, plus conversion plants in China and Australia. Specialty sites include Jordan, the U.S., Germany, and Taiwan.
Business Segments
Competitive Landscape
Albemarle's 10-K lists major lithium compounds competitors as SQM, Sichuan Tianqi Lithium, Jiangxi Ganfeng Lithium, Rio Tinto, Pilbara Minerals, Tesla, and a large number of Chinese companies. In Specialties, the most significant competitors are Lanxess, Israel Chemicals, and Rio Tinto, plus producers in India and China. The record does not describe Albemarle as having a sole-source position; competitive pressure comes from both Western and Chinese conversion and resource development.
- Sociedad Quimica y Minera de Chile S.A. (SQM)10-K lists SQM as a major lithium compounds competitor; not discussed.
- 10-K lists Rio Tinto in both lithium compounds and Specialties; not discussed.
- Tesla10-K lists Tesla among lithium compounds competitors; not discussed.
- Pilbara MineralsNamed in 10-K lithium compounds competitor list; not discussed.
- Lanxess AG10-K names it as a most significant Specialties competitor; not discussed.
Supply Chain
Albemarle sits at the upstream-to-midstream lithium conversion layer, with brine and hard-rock resources supplying lithium salts to battery and cathode customers.
More on ALB: Earnings recap